Cargando…
Early Ear, Nose and Throat Manifestations in Eosinophilic Granulomatosis with Poliangioitis: Results from Our Cohort Group and Literature Review
Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare, systemic necrotizing vasculitis affecting small-to-medium-sized vessels. EGPA’s clinical manifestations are heterogeneous, affecting different organs and systems, and the upper respiratory tract can be affected by ear, nose and throat (...
Autores principales: | D’Onofrio, Mario, La Prova, Daniele, Galdiero, Maria Rosaria, Cantone, Elena, Tremante, Eugenio, Mascolo, Massimo, Barbieri, Vittoria, Di Nola, Claudio, Spadaro, Giuseppe, de Paulis, Amato, Detoraki, Aikaterini |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10672482/ https://www.ncbi.nlm.nih.gov/pubmed/38002582 http://dx.doi.org/10.3390/jcm12226967 |
Ejemplares similares
-
A Multidisciplinary Approach for Type 2 Allergic Diseases: What Do Biologics Teach Us?
por: Maniscalco, Mauro, et al.
Publicado: (2023) -
Exhaled Nitric Oxide as Biomarker of Type 2 Diseases
por: Maniscalco, Mauro, et al.
Publicado: (2023) -
Mepolizumab improves sino-nasal symptoms and asthma control in severe eosinophilic asthma patients with chronic rhinosinusitis and nasal polyps: a 12-month real-life study
por: Detoraki, Aikaterini, et al.
Publicado: (2021) -
Real-world characteristics of “super-responders” to mepolizumab and benralizumab in severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis
por: Portacci, Andrea, et al.
Publicado: (2023) -
Real-life evidence of low-dose mepolizumab efficacy in EGPA: a case series
por: Detoraki, Aikaterini, et al.
Publicado: (2021)